BioSpace News Archive

Career Advice

How to Be More Likable During an Interview

The concept of company culture is a hot topic in the workplace now. Here are some tips to help you be more likable during an interview.

May 16, 2019
·
3 min read
·
Porschia Parker-Griffin
Drug Development

MacroGenics Thrives Following Positive Breast Cancer Results

The trial evaluated margetuximab in patients with HER2-positive metastastic breast cancer who had already been treated with anti-HER2-targeted therapies.

May 16, 2019
·
3 min read
·
Mark Terry
Policy

Gilead and Other HIV Treatment-Making Companies Face Class Action Lawsuit

The plaintiffs allege that Gilead and other companies used anticompetitive tactics to keep prices artificially high for their respective HIV treatments.

May 16, 2019
·
3 min read
·
Alex Keown
Biotech Bay

Research Roundup: How Viruses Replicate, Food Additives, Stroke and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

May 16, 2019
·
6 min read
·
Mark Terry
Business

Teijin Establishes Nutraceutical Product Firm for Productive Aging

Teijin Limited announced today its establishment of NOMON, Co., Ltd. to sell nutraceutical food and beverages that are scientifically proven to help people maintain their health.

May 16, 2019
·
1 min read
Drug Development

Atriva Therapeutics Starts Clinical Development of Novel Host-Targeting Antiviral ATR-002 Against Influenza

Phase I clinical trial to evaluate safety and tolerability of ATR-002 in healthy volunteers

May 16, 2019
·
4 min read
Pharming Today Celebrates “hae day :-)” – the Global Awareness Day for Hereditary Angioedema, a Rare Life-threatening Condition

Pharming Group N.V. today supports world “hae day :-)”.

May 16, 2019
·
5 min read
Business

GeoVax Observes HIV Vaccine Awareness Day And Prepares for Next Human Clinical Trial of GOVX-B11

Recognizing the Support of the National Institutes of Health and the

May 16, 2019
·
5 min read
Drug Development

Ad hoc: Primary Endpoint of L-MIND, a Combination Study of Tafasitamab (MOR208) and Lenalidomide, has been met, Confirming Previously Published Activity

MorphoSys AG today announced results from the primary analysis (cut-off date November 30, 2018) of the ongoing single-arm phase 2 clinical trial known as L-MIND.

May 16, 2019
·
6 min read
Business

Parvus and Genentech Forge Autoimmune Collaboration

Financial terms of the deal were not disclosed, but Genentech aims to use Parvus’ technology to target IBD and Celiac.

May 16, 2019
·
2 min read
·
Alex Keown